NCT06281730
Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy
Enrolling by Invitation
NAAges 18+InterventionalPreventionMayo ClinicInvestigator-initiated
~100 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:Karl Storz New Generation Fetoscope - curved 11508AAKKarl Storz New Generation Fetoscope - straight 11506AAK
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adverse events
Measured over 12 months
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Mauro Schenone, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patient is a pregnant woman 18 and older
The mother must be healthy enough to have surgery
The mother must be scheduled for surgery
Patient provides signed informed consent that details the maternal and fetal risks involved with the procedure
Exclusion
Age \<18 years
Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia
Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor) in the index pregnancy.
Fetal aneuploidy, any significant pathogenic or likely significant pathogenic findings on Karyotype or Microarray (if available, but not required), other major fetal anomalies that impacts significantly the fetal/neonatal survival.
What this trial measures
- Adverse events12 months
The count of subjects who experience adverse events
- Serious Adverse Events12 months
The count of subjects who experience serious adverse events
- Device malfunctions12 months
The number of device malfunction incidents